Importantly, we determined the impact of KDM4A KD on AML initiation in vivo by transplanting KDM4A KD THP1 cells (Fig. 1I) or primary AML cells (Fig. 1J–K and S1F–S1H) into recipient NSG mice. The gene discussed is KDM4A; the disease is acute myeloid leukemia.